Warning letterFDA · Sep 7, 2021
Metamune Inc MARCS-CMS 614543, September 07, 2021
Named company: Metamune Inc
A drug is misbranded under section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)] if the drug fails to bear adequate directions for its intended use(s). Accordingly, DiabetesSupport, fails to bear adequate…
Lot information: not specified in this record.